Marek's disease virus (MDV) is an important oncogenic alphaherpesvirus that induces rapid-onset T-cell lymphomas in its natural hosts. The Meq-clustered miRNAs encoded by MDV have been suggested to play potentially critical roles in the induction of lymphomas. Using the technique of bacterial artificial chromosome mutagenesis, we have presently constructed a series of specific miRNA-deleted mutants and demonstrate that these miRNAs are not essential for replication of MDV and have no effects on the early cytolytic or latent phases of the developing disease. However, compared to the parental GX0101, mortality of birds infected with the mutants GXDmiR-M2, GXDmiR-M3, GXDmiR-M5, GXDmiR-M9 and GXDmiR-M12 was reduced from 100 % to 18 %, 30 %, 48 %, 24 % and 14 %, coupled with gross tumour incidence reduction from 28 % to 8 %, 4 %, 12 %, 8 % and 0 %, respectively. Our data confirm that except for mdv1-miR-M4, the other Meq-clustered miRNAs also play critical roles in MDV oncogenesis. Further work will be needed to elucidate the miRNA-mediated regulatory mechanisms that trigger the development of MD lymphomas.
INTRODUCTION
During the past decade, microRNAs (miRNAs), a family of small non-coding RNAs, have been widely investigated and have been shown to display post-transcriptional regulatory functions in cellular development, differentiation and all aspects of cancer biology (Bartel, 2004; Filipowicz et al., 2008; Lee & Dutta, 2009 ). Hundreds of viral miRNAs have been unexpectedly discovered in diverse virus families (Grundhoff & Sullivan, 2011; Kincaid & Sullivan, 2012) and some of the miRNAs encoded by oncogenic herpesviruses, such as Epstein-Barr virus (EBV), Kaposi's sarcomaassociated herpesvirus (KSHV) and Marek's disease virus (MDV), have recently been demonstrated to be potentially involved in viral pathogenesis and/or tumorigenesis (Boss et al., 2009; Morgan & Burnside, 2011) . Serotype 1 MDV (MDV-1), belonging to the subfamily Alphaherpesvirinae and recently reclassified as the species Gallid herpesvirus 2 (Davison et al., 2009) , is one of the most potent oncogenic herpesviruses. The virulent strains of MDV-1 can establish and maintain latent infections in their natural hosts, leading to a highly contagious, neoplastic lymphoproliferative disease of poultry, namely Marek's disease (MD) (Witter & Schat, 2003; Nair & Kung, 2004) . However, formation of tumours can be prevented by immunization with attenuated or non-pathogenic forms of MDV viruses (Jarosinski et al., 2006) , providing the first demonstration of the efficacy of antiviral vaccination in the control of a cancer. Thus MD is considered to be an excellent biomedical model for the study of virally induced lymphoma . Although the molecular mechanisms for the induction of lymphoma by MDV have long provided a focus for research, among the more than 100 viral genes only the MDV-1-specific gene meq (MDV EcoRI-Q), encoding a basic leucine zipper protein, has been characterized as a major oncogene (Nair & Kung, 2004) ; other fundamental molecular determinants that may trigger tumour development remain unknown.
A large number of miRNAs are encoded in the genomes of all three serotypes of MDV (Burnside et al., 2006; Yao et al., 2007 Yao et al., , 2008 Yao et al., , 2009 Waidner et al., 2009) . In MDV-1 genomes, the viral miRNAs are focused in three gene clusters, as illustrated in Fig. 1 , namely Meq-cluster, midcluster and LAT-cluster, respectively (Luo et al., 2010) . Previous studies have shown that most of the MDV-1-encoded miRNAs are expressed at higher levels in splenic tumours and virally transformed T-lymphoma cell lines than in the standard virus-infected chicken embryo fibroblast (CEF) cultures (Burnside et al., 2006; Yao et al., 2008) . In vivo expression profiles at different phases of the developing disease show that different subsets of miRNAs are expressed, suggesting their different regulatory roles in MD pathogenesis (Luo et al., 2011) . Although the sequences of miRNA are highly conserved among oncogenic MDV-1 strains of differing virulence, the Meq-clustered miRNAs are expressed at higher levels in lymphomas produced by very virulent plus (vv+) MDV than those produced by a less very virulent (vv) MDV strain, whereas the LATclustered miRNAs expression is equal (Morgan et al., 2008) , implying that the Meq-clustered miRNAs may be more significant in MDV oncogenesis.
The Meq-clustered miRNAs, i.e. mdv1-miR-M9, mdv1-miR-M5, mdv1-miR-M3, mdv1-miR-M12, mdv1-miR-M2 and mdv1-miR-M4, are sequentially located upstream from the meq oncogene (Burnside et al., 2006; Yao et al., 2008) in the first intron of the transcripts covering the IR L /TR L region, and its transcription is driven by a single promoter, prmiRM9M4, under two distinct transcriptional models during different infection phases (Coupeau et al., 2012) . The miRNA mdv1-miR-M4, similar to the KSHV-encoded miR-K12-11 (Gottwein et al., 2007) , has been characterized as the second virus-encoded functional orthologue of cellular miR-155 and specifically inhibits the translation of viral proteins involved in the cleavage/ packaging of herpesvirus DNA (Muylkens et al., 2010) . Since miR-155 is a host-encoded miRNA associated with several cancers (Faraoni et al., 2009; Tili et al., 2009 ), mdv1-miR-M4 was also hypothesized to play a critical role in MDV oncogenesis. Using the reverse genetics technique of infectious bacterial artificial chromosome (BAC) cloning, a recent study has reported that the deletion of mdv1-miR-M4 from the viral genome of a virulent (v) MDV strain pRB-1B5
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Mid-cluster LAT-cluster US IRS Fig. 1 . Schematics of MDV-1-encoded miRNAs. The relative genomic locations of MDV-1-encoded miRNAs are shown by solid and dashed lines. miRNA precursors (pre-miR) and miRNA gene clusters (miR-cluster) are shown by green hairpins or arrows, respectively. Mature miRNAs (mat-miR), passenger miRNAs (miRNA*) and unstable miRNAs (unstable-miR) could greatly reduce the oncogenicity of the virus (Zhao et al., 2011) , providing evidence for a direct role in vivo of a viral miRNA in tumour induction. In addition, miRNA mdv1-miR-M3 in the Meq-cluster was also found to play an important regulatory role in MDV oncogenesis , targeting and downregulating the expression of Smad2, a critical component in the transforming growth factor beta (TGF-b) signal pathway, and prolongs the longevity of infected cells. In an earlier study (Yu et al., 2014) , we had found that in addition to the virus-encoded miR-155 orthologue, some of the other Meq-clustered miRNAs may also play potentially critical roles in vvMDV induction of lymphoma. Using a vvMDV strain GX0101 (Sun et al., 2009) , we have now constructed a series of miRNA-deletion mutants by BAC mutagenesis and confirm that most of the Meq-clustered miRNAs have differing roles in the induction of MD lymphomas. These studies provide further information for understanding the molecular determinants that trigger the development of tumours by oncogenic MDVs.
RESULTS

Verification of deletions of miRNA genes from the GXDmiR-BAC clones
To evaluate the potential roles of the individual Meqclustered miRNAs involved in MDV oncogenesis, a series of BAC clones each with a corresponding deletion of the miRNAs mdv1-miR-M2, mdv1-miR-M3, mdv1-miR-M5, mdv1-miR-M9 or mdv1-miR-M12, located in the Meqcluster, as shown in Fig. 1 , were constructed by mutagenesis based on a full-length infectious BAC clone of the vvMDV strain GX0101 (Sun et al., 2009) . The deletions of the miRNA-located regions of the recombinant BAC DNAs were verified by PCR analysis using purified GX0101-BAC and GXDmiR-BAC as templates and the different specific primer pairs listed in Table S1 (available in the online Supplementary Material). Agarose gel electrophoresis of PCR products showed that identical products of the three MDV genes, meq, pp38 and gB, were generated by PCR on all six templates (Fig. 2, left) , demonstrating that the mutagenesis steps had not affected the replication of the recombinant BACs. The presence of bands of both Kanamycin (Kan) resistance gene and primary miRNA (primiR) fragments indicate the chimeric regions in GXDmiR-BACs compared to GX0101-BAC, whereas the changed bands of precursor miRNA (premiR) fragments demonstrate the deletions of the miRNA genes from GXDmiR-BAC DNAs (Fig. 2, left) . Further confirmation was produced by DNA sequence analysis (Table S2) .
Characterization of the mutant MDVs reconstituted from GXDmiR-BACs
GXDmiR viruses were reconstituted by transfection of GXDmiR-BAC DNAs into CEFs. Characteristic MDV plaques were visible at 5-7 days post-transfection. The plaques produced by all five of the reconstituted viruses and the parental virus GX0101 were indistinguishable from each other. Specific staining of the viral plaques, but not of control non-transfected CEFs, with MDV gB-specific monoclonal antibody further confirmed the specificity of the viral plaques (data not shown). As demonstrated in Fig. 2 (right) and Table S2 , both PCR analysis using the reconstituted viral genomic DNAs as templates and subsequent sequence analysis gave exactly the same results as those using BAC DNAs as templates. Furthermore, quantitative real-time PCR (qRT-PCR) analysis showed that the neighbour miRNAs in the Meq-cluster were normally expressed in GXDmiR virus-infected CEFs, without significant difference compared to those of parental virus GX0101, except for the undetectable mutated miRNAs (Fig. 3) . These data confirm the successful deletions of the corresponding miRNAs from the viral genomes of reconstituted viruses GXDmiR-M2, GXDmiR-M3, GXDmiR-M5, GXDmiR-M9 and GXDmiR-M12.
In vitro and in vivo replication of GXDmiR viruses
qRT-PCR was performed on infected CEFs and showed very similar replication kinetics for both the parent GX0101 and mutant viruses (Fig. 4a, b) , indicating that the Meq-clustered miRNAs were not essential for MDV replication in vitro. The in vivo growth kinetics also showed that the Meq-clustered miRNAs are not essential for replication of MDV. However, the deletions in the Meqcluster locus were not without effect on in vivo viral replication. As shown in Fig. 4(c, d) , GX0101 virus was detected in infected birds as early as 1 day post-infection (p.i.) and the viraemia increased during the following three weeks, peaking at about 30 days p.i., and then declined rapidly during the last month of the experiment. With the individual miRNA-deleted viruses the levels of viraemia were more variable, but in general, after an increase over the first seven days it levelled out, never achieving the maximal levels seen with GX0101.
Influence of the deletion of miRNA genes on growth rates of birds To compare the pathogenicity of the mutant viruses with their parental virus, we examined the growth rates of infected birds. The experimental groups, each consisting of 80 one-day-old chickens, were separately challenged with GX0101 or mutant viruses by abdominal cavity inoculation while the negative control birds were inoculated with an equal volume of uninfected CEFs. As shown in Fig. 5 (a), no difference in body mass of birds in all seven groups was observed in the first week post-challenge. GX0101 strongly inhibited the growth rates of infected birds between 14 and 30 days, after which surviving birds appeared to grow normally. The birds infected with miRNA-deleted viruses did not show this marked reduction in growth after 14 days p.i., although GXDmiR-M3 or GXDmiR-M5-challenged birds had body masses which were lower at 21 and 30 days p.i. than those of the CEF controls.
Influence of the deletion of miRNA genes on immune organs of birds
As demonstrated in Fig. 5 (b, c), for the first week postchallenge there was little or no change in the bursa/ body mass or thymus/body mass ratios of the birds in each group. By 14 days there was a fall in the ratios, particularly in the thymus/body mass ratio. The bursa/ body mass ratios of birds inoculated with the parental GX0101 or the mutant viruses were significantly lower (P,0.05) than that of the control birds at 21 days p.i. But there was no consistent significant difference between GX0101 and the deletion mutants in this ratio (Fig. 5b) . Fig. 2 . Comparison of the PCR products amplified from the BAC clones and reconstituted viral genomes of GX0101 or its miRNA-deleted mutants. PCR products using the BAC DNAs as templates are shown on the left side while those using the corresponding viral genomic DNAs are on the right side. Primer pairs used for performing the PCR analysis and their corresponding amplicons are listed in Table S1 . Meq, MDV EcoRI-Q gene; pp38, phosphorylated protein 38 gene; gB, glycoprotein B gene; Kan, kanamycin gene; primiR, primary miRNA; premiR, miRNA precursor; OVO, chicken ovotransferrin gene.
Similarly, there was no difference in the thymus/body mass ratios between the parental virus and its mutants, although all groups of infected birds showed a marked fall compared to the CEF control group (Fig. 5c ).
Pathogenicities of parental GX0101 and the derivative mutant viruses
Post-challenge, as demonstrated in Table 1 , the GX0101-infected group developed MD rapidly, with most of the birds showing classic clinical signs and mortality starting as early as 7 days p.i., continuing at an increasing rate until all had died by 75 days p.i. By comparison, birds inoculated with the mutant viruses did not show obvious signs of MD until about 21 days p.i. and exhibited low mortality throughout the experimental period. Thus, although by 90 days p.i., when there were no surviving birds from the GX0101-challenged group, 82 %, 70 %, 52 %, 76 % and 86 % of the birds infected with GXDmiR-M2, GXDmiR-M3, GXDmiR-M5, GXDmiR-M9 or GXDmiR-M12, respectively, remained alive (Fig. 6 ). By 75 days p.i., when all of the GX0101-infected birds were dead and 28 % of the birds had developed gross tumours in different tissues or organs (mainly concentrated in spleens, livers and proventriculus); in contrast, of the birds infected with GXDmiR-M2, GXDmiR-M3, GXDmiR-M5 or GXDmiR-M9, 8 %, 4 %, 12 % and 8 %, respectively, had developed gross tumours. In the GXDmiR-M12-infected birds no gross tumours were found (Table 1) . By the end of the experimental time period of 90 days, the total gross tumour incidences recorded for the GXDmiR-M2, GXDmiR-M3, GXDmiR-M5, GXDmiR-M9 or GXDmiR-M12-infected birds rose to 32 %, 20 %, 30 %, 32 % and 10 %, respectively. These results showed that compared to the parental GX0101 virus, the pathogenicity and oncogenicity of the serial mutants were strongly suppressed.
Pathological lesions and tumorigenesis induced by MDVs
To further examine the progress of tumorigenesis in the deletion mutants, three birds from each group inoculated with the parental virus GX0101 or the mutated viruses and showing no gross organic tumours at 30, 60 and 90 days p.i. were randomly selected and their livers examined histologically. As demonstrated in Table S3 , tumour foci were first observed in the livers of a few birds infected with viruses GX0101, GXDmiR-M2, GXDmiR-M3 or GXDmiR-M12 at 30 days p.i. and subsequently at 60 (Fig. 7) or 90 days p.i., the positive rates of tumorigenesis in each group increased and finally achieved 100 %, 100 %, 100 % or 66.7 %, respectively. However for the GXDmiR-M5 or GXDmiR-M9-infected groups, tumour foci were observed in livers of all the examined birds from 30 days p.i. Numbers of tumour foci in the positive birds induced by MDVs were obtained but no significant differences were found amongst the parental and/or mutant viruses (data not shown). No tumours were seen in the control group. These results further indicate that oncogenicity was not completely abolished in the mutant viruses but tumour progression was retarded compared to that of the parental GX0101 virus.
DISCUSSION
The recent introduction of the technique of BAC mutagenesis has facilitated manipulation of the large herpes virus genomes, including that of MDV, enabling further studies of pathogenicity and the production of modified viruses to use in vaccines (Schumacher et al., 2000; Petherbridge et al., 2003 Petherbridge et al., , 2004 Sun et al., 2009 ). In our experience (Sun et al., 2009 Yu et al., 2014) , the technique is more difficult for the manipulation of shorter miRNA genes compared to its use with large viral genes; however, we have been able to verify that BAC mutagenesis is applicable to the deletion of single miRNA sequences to reveal their potential biological roles. Based on BAC mutagenesis of an infectious BAC clone derived from the vvMDV strain GX0101 (Sun et al., 2009) , we have constructed a series of MDV mutants with single deletions of each (except for the mdv1-miR-M4 that has already been studied; Yu et al., 2014) of the Meq-clustered miRNAs. Our data showed that all five of the miRNAdeleted mutants, including GXDmiR-M2, GXDmiR-M3, GXDmiR-M5, GXDmiR-M9 and GXDmiR-M12, gave similar rates of replication in CEFs compared to the parent virus GX0101. Replication in vivo, as assessed by the level of viraemia, of all viral variants was much more variable. The in vivo growth rates for the mutant viruses and parent GX0101 were initially similar, but after the first week the GXDmiR-M2 GXDmiR-M3 GXDmiR-M5 Fig. 4 . In vitro and in vivo replication of MDV strain GX0101 and the miRNA-deletion mutants. Viral genome copy numbers of the parental virus and its mutants per 10 6 cells, estimated based on MDV meq and gB genes, were determined using a real-time qPCR on DNA extracted from CEFs (a, b) or bird's blood (c, d) sampled at various time points after virus infection or inoculation. For the GX0101 group, there are no data available at 75 and 90 days p.i. because there were no living birds at these times post-challenge.
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level of viraemia for the mutants tended to level out, not reaching the maximum shown by GX0101.
The course of MD is well described in the 'Cornell model' (Calnek, 2001) , which includes four phases: (i) the early cytolytic phase (2-7 days p.i.), (ii) the latent phase (7-10 days p.i. onwards), (iii) the late cytolytic and immunosuppressive phase (18 days p.i. onwards) and (iv) the proliferative phase (28 days p.i. onwards) (Baigent & Davison, 2004) . Together with our previous work (Yu et al., 2014) , the present data suggest that the Meqclustered miRNAs are not essential for the replication of MDV, and that their individual deletion did not affect the early cytolytic phase or the latent phase of MDV infection.
Similarly to the MDV mutants GXDMeq-miRs and GXDmiR-M4 (Yu et al., 2014) , deletion of any of the other five Meq-clustered miRNAs from the GX0101 genome induced damage of both the bursa of Fabricius and thymus as assessed by their relative masses compared to that in birds infected with the parental virus GX0101. This might imply that there is no correlation between the Meq-clustered miRNAs and the injury to immune organs caused by MDV infection. However, we did not measure the bird's immune response to the injected viruses. Except for mdv1-miR-M5, the body mass of birds infected with the miRNA-deleted viruses was not strongly affected compared to the controls, and did not show the inhibition seen at 21-30 days in GX0101-infected birds. Most importantly, the animal experiments further showed that deletions of the individual Meq-clustered miRNA variably decreased the pathogenicity and oncogenicity of this strain. Although the deletion of mdv1-miR-M2 interrupted the overlapping R-LORF8 gene, a recent report has shown that this gene is not a major determinant of oncogenicity (Zhao et al., 2011) . Compared to the parental virus GX0101 during the whole experimental time period, mortalities of Comparisons of the growth rates (a) and the ratios of bursa (b) or thymus (c) over body mass of birds challenged with distinct MDVs. For each group, the body masses, bursa masses and thymus masses of six randomly selected surviving birds were measured at different time points post-challenge. Black and red stars indicate significant differences (P,0.05) to CEFs or GX0101 controls, respectively. There are no data applicable for GX0101 at 75 and 90 days p.i. due to the death of all birds before these times post-challenge.
Role of the Meq-clustered miRNA in MDV oncogenesis the mutant viruses GXDmiR-M2, GXDmiR-M3, GXDmiR-M5, GXDmiR-M9 and GXDmiR-M12 were reduced from 100 % to 18 %, 30 %, 48 %, 24 % and 14 %, respectively. As for the oncogenicity at 75 days p.i., by which time all of the GX0101-challenged birds were dead, gross tumour incidence reduced from 28 % in the GX0101-infected birds, to 8 %, 4 %, 12 %, 8 % and 0 % in the GXDmiR-M2, GXDmiR-M3, GXDmiR-M5, GXDmiR-M9 and GXDmiR-M12-challenged birds, respectively. These results mirror our previous work (Yu et al., 2014) , in which the mortalities of MDV mutants GXDmiR-M4 and GXDMeq-miRs were reduced from 100 % in the parental virus GX0101 to 18 % and 4 %, and cumulative gross tumour incidence fell from 28 % to 22 % and 8 %. These current results suggest that the Meqclustered miRNAs, other than the virus-encoded miR-155 orthologue mdv1-miR-M4, have different oncogenic roles in the induction of MD lymphomas.
Mdv1-miR-M4, one of the most highly expressed Meqclustered miRNAs in vivo (Morgan et al., 2008; Luo et al., 2011) , has been previously characterized as a virus-encoded miR-155 orthologue and has been preliminarily implicated in MDV oncogenesis (Muylkens et al., 2010) . Using BAC mutagenesis, a recent study had shown that that the deletion of mdv1-miR-M4 from the viral genome of an infectious BAC clone, pRB-1B5, Table 1 . Cumulative death and gross tumour occurrence in chickens challenged by MDV-1 strain GX0101 and its miRNA-deleted mutants at different time points post-infection
Time point
Strain & category GX0101 GXDmiR-M2 GXDmiR-M3 GXDmiR-M5 GXDmiR-M9 GXDmiR-M12 CEFs abolished the oncogenicity of the virus (Zhao et al., 2011) . Interestingly, our present and previous work using the same technique with the infectious BAC clone GX0101 has shown that deletions of the mdv1-miR-M4 or the other Meq-clustered miRNAs alone from the viral genome strongly decreased rather than abolished the oncogenicity of this strain. The differences in the oncogenicity of the mutant viruses produced from pRB-1B5 and GX0101 may originate from the following differences between the studies: (i) the adopted experimental protocols, i.e. the higher infecting doses of GX0101 and its mutant MDVs (2000 p.f.u. for each bird) possibly causing a more rapid onset and progression of disease, the larger numbers of birds (n580) in each experimental group and the longer experimental period of 90 days; (ii) the differences in virulence between the parental viruses GX0101 and pRB-1B5. The BAC clone of GX0101 remains highly oncogenic, retaining the original pathogenicity and oncogenicity of its parent virus GX0101 (Sun et al., 2009; Cui et al., 2010) while the pathogenicity of the derived strain from pRB-1B5 was significantly lower (P,0.0001) than that of the original virus pRB-1B (Petherbridge et al., 2004; Zhao et al., 2008) ; (iii) the possible differential susceptibilities of chicken lines, the white Leghorn used in the present study and P-line (MHC type B 19 /B 19 ) used previously (Zhao et al., 2011) . Whatever the reasons, the differences are ones of degree; the results obtained from mutant MDVs of both vMDV and vvMDV strains support the suggestion that most of the Meqclustered miRNAs play a part in MDV oncogenicity.
Given the fact that a miRNA may have multiple targets and an mRNA target can be regulated by more than one miRNA, the signalling network mediated by miRNAs can be far more complicated than expected. Another Meq-clustered miRNA highly expressed in vivo, mdv1-miR-M3, has been suggested to contribute to the induction of MD lymphomas by targeting Smad2 of the TGF-b pathway , an important signal pathway associated with the development of lymphoma (Rai et al., 2010) . Except for the previously reported cellular and viral target genes (Muylkens et al., 2010) , recent studies in our laboratory have found that mdv1-miR-M4-5p also regulates the TGF-b pathway by targeting LTBP1, the latent transforming growth factor-b binding protein 1 (Chi et al., 2015) . This suggests that at present, at least two Meq-clustered miRNAs have been found to simultaneously regulate MDV tumorigenesis by targeting different genes in the same signalling network. Studies of the miRNA expression signatures in cancers have increased our understanding of the connections between miRNA and tumorigenesis (Calin & Croce, 2006) . Our previous work had found that, similarly to mdv1-miR-M4-5p and mdv1-miR-M3-5p, the mature miRNAs mdv1-miR-M12-3p in the Meq-cluster, mdv1-miR-M1-5p in the midcluster, and mdv1-miR-M7-5p and mdv1-miR-M8-3p in the LAT-cluster have also been shown to be early expressed miRNAs during different phases of the developing disease (Luo et al., 2011) . Whether such early expressed miRNAs encoded in distinct miRNA gene clusters and other potential molecular determinants trigger the development of lymphoma remains to be uncovered. Along with the development of mRNA target identification strategies and the applications of BAC techniques in research on herpesvirus pathogenesis, it is expected that further understanding of the biological functions of virus-encoded miRNAs will naturally follow.
METHODS
Viruses. An infectious BAC-derived vvMDV strain GX0101 (Sun et al., 2009 Cui et al., 2010; Su et al., 2012) was used as the parental virus to construct the miRNA-deletion mutants.
Chickens. Experiments were conducted in commercial specificpathogen-free (SPF) white Leghorn chickens (Jinan SPF Egg & Poultry) that were maintained in isolators with filtered air under positive pressure in an SPF animal facility (Pulike Biological Engineering).
Construction of the BAC clones of GXDmiR. Construction of a series of individually Meq-clustered miRNA-deleted GX0101-BAC clones, namely GXDmiR-M2-BAC, GXDmiR-M3-BAC, GXDmiR-M5-BAC, GXDmiR-M9-BAC and GXDmiR-M12-BAC, was carried out as described previously (Yu et al., 2014) . Briefly, Escherichia coli EL250 cells transformed with GX0101-BAC containing the whole genome of GX0101 were prepared by inoculating a fresh overnight culture into 10 ml of Luria-Bertani (LB) medium containing chloramphenicol (25 mg ml 21 ) until an optical density at 600 nm of 0.5 was reached. Then, expression of recE, recT and l gam was induced by incubation at 42 uC for 15 min and cells were collected for the preparation of electrocompetent cells by a standard protocol (Muyrers et al., 1999; Narayanan et al., 1999) . Kan R cassettes flanked by FRT sites were amplified using primers miR2F-Kan Table S1 ) from pKD13 (Datsenko & Wanner, 2000) . 
Role of the Meq-clustered miRNA in MDV oncogenesis
After digesting with DpnI to remove the residual pKD13 template, the PCR products were electrophoresed and purified using Gel Extraction kit (Omega). About 300 ng of the PCR products were electroporated into 50 ml of electrocompetent EL250 cells harbouring the GX0101-BAC using standard electroporation parameters (2.0 kV, 200 V and 25 mF). After electroporation, the cells were grown in 1 ml of SOC medium (Sigma) for 2 h and spread onto LB agar plates containing chloramphenicol (25 mg ml
21
) and kanamycin (50 mg ml
). Resistant colonies were picked and grown in liquid LB medium. Excision of the Kan R cassettes was carried out by induction of FLPe recombinase by adding 0.1 % arabinose into the medium. To delete the second miRNA allele from the TR L or IR L regions, another round of BAC mutagenesis was performed in the same way. Finally, the EL250 cells harbouring GXDmiR-M2-BAC, GXDmiR-M3-BAC, GXDmiR-M5-BAC, GXDmiR-M9-BAC or GXDmiR-M12-BAC were grown up and the BAC DNA was prepared using Plasmid Midi kits (Qiagen) according to the manufacturer's instructions.
Confirmation of the deletion of miRNAs from GXDmiR-BACs.
The existence of the GX0101 genome and deletion of the individual Meq-clustered miRNAs from the GXDmiR-BAC DNAs were confirmed by PCR using primers that amplify different viral genomic regions or genes (primer pairs 6-18), kanamycin resistance gene (primer pair 19) and chicken ovotransferrin gene (primer pair 20) as shown in Table S1 . For further confirmation, all corresponding PCR products were conventionally cloned and sent to SangonBiotech (Shanghai, China) for DNA sequencing.
Reconstitution and confirmation of miRNA-deleted MDVs. For the rescue of MDV virus, the BAC DNA was transfected into CEF using Lipofectamine according to manufacturer's instructions (Invitrogen). Briefly, 1 mg DNA and 10 ml Lipofectamine were each diluted in 100 ml opti-MEM in separate tubes. The two solutions were mixed gently and left at room temperature for 45 min, after which the volume was increased to 1 ml. CEFs were seeded into 6-well plates 1 day prior to transfection, and after washing the monolayer twice with opti-MEM, the DNA/Lipofectamine mixture was added to each well. After incubating the cells at 37 uC for 6 h, 1 ml growth media was added to each well. The transfected cells were incubated for several days until specific viral plaques appeared. Characterization of reconstituted viruses by indirect immunofluorescence assay (IFA) was performed as described previously (Sun et al., 2009) . After three rounds of passage to enrich the viral titres, GXDmiR-M2, GXDmiR-M3, GXDmiR-M5, GXDmiR-M9 or GXDmiR-M12 virus stocks were stored in liquid nitrogen. As described above, the deletions of Meqclustered miRNA from the viral genomes were confirmed by PCR and the products were cloned and sent for DNA sequencing.
Titration and in vitro proliferation of MDVs on CEFs. The p.f.u. of both GX0101 and miRNA-deleted MDVs were measured using CEF monolayer cultures in 96-well plates as described previously (Luo et al., 2011) . To investigate the in vitro virus proliferation rates, CEF monolayers on 6-well plates were separately infected with 100 p.f.u. GX0101 or miRNA-deleted mutants and sampled at 0, 24, 48, 72, 96, 120 and 144 h p.i. Total DNAs were extracted using commercial DNA Extraction kits (TaKaRa) and the qRT-PCR assays were separately performed with modification from previous reports (Baigent et al., 2005; Abdul-Careem et al., 2006) . Briefly, the 20 ml PCR included 10 ml 26 SYBR Premix Ex Taq (TaKaRa), 1 ml DNA template (50 ng ml 21 ), 8.2 ml sterilized double distilled water (ddH 2 O) and 0.8 ml of each primer pairs (10 mM) that are specific for MDV meq or gB genes and the chicken ovotransferrin (OVO) gene (primer pairs 21-23, Table S1 ), and the reaction sequence was 95 uC for 3 min, and 40 cycles of 95 uC for 15 s followed by 60 uC for 1 min, using the 7500 Fast Real-Time PCR System (Applied Biosystems, Life Technologies). Finally, the number of viral genome and OVO gene copies was estimated by the use of a standard curve, which was simultaneously generated by the qRT-PCR described above, using DNA templates of the 10-fold serial dilutions (10 9 to 10 1 copies) of pMD18-T plasmids containing MDV meq, gB or chicken OVO genes of which the copy number was calculated from the concentration of plasmid DNA and its molecular mass. Since the meq gene is found twice in the viral genome and the OVO gene is found twice in a diploid cell, quantification of the MDV genome (virus copy number per 10 6 CEF cells) was expressed as the ratio of the numbers of meq copies or 26gB copies per 10 6 copies of the OVO gene.
qRT-PCR analysis of viral miRNA expressions in MDV-infected CEFs. As described above, the CEF cultures separately infected with GX0101 or its mutants were sampled at 144 h p.i. Total RNAs were extracted using TRIzol reagent (Invitrogen) and the expression levels of viral miRNAs were measured by qRT-PCR. For cDNA synthesis, aliquots of 100 ng RNAs were polyadenylated and reverse transcribed at 37 uC for 1 h in a 20 ml reaction mixture, using the NCode VILO miRNA cDNA Synthesis kit (Invitrogen) according to the manufacturer's instructions. For the absolute quantification of miRNAs, qPCR was performed. Briefly, a total of 20 ml qPCR containing 1 ml cDNA, 10 ml SuperMix Universal, 0.4 ml Universal qPCR Primer (10 mM), 0.04 ml ROX Reference Dye (25 mM) (Invitrogen), 8.16 ml ddH 2 O and 0.4 ml of each miRNA-specific forward primer (10 mM) (Table S1 , primers 24-29) was prepared. The 7500 Fast Real-Time PCR System (Applied Biosystems, Life Technologies) was used for qPCR amplification with the reaction conditions set as follows: 95 uC for 3 min, 40 cycles of 95 uC for 3 s and 60 uC for 30 s, followed by the thermal denaturing step to generate the dissociation curves to verify amplification specificity. Synthetic miRNA mdv1-miR-M4-5p (GenePharma) ( Table S1 , primer 30) was used as the standard to estimate the absolute miRNA copy number. The virus infections were performed in triplicate independent experiments. Each of the PCRs was repeated in triplicate and the values used to calculate the means (M)±standard deviations (SD), utilizing the software GraphPad Prism (version 5.0).
Animal experiments. The animal experiments with chickens were performed following the local protocols of the Ethical and Animal Welfare Committee of Key Laboratory of Animal Immunology of the Ministry of Agriculture of China, simultaneously with those reported by Yu et al. (2014) and utilizing the same control groups. In addition to those reported, an additional five experimental groups, each of 80 one-day-old white Leghorn SPF chickens, were separately challenged with CEFs containing 2000 p.f.u. of GXDmiR-M2, GXDmiR-M3, GXDmiR-M5, GXDmiR-M9 or GXDmiR-M12 viruses by abdominal cavity inoculation. Post-challenge, birds were inspected regularly for any clinical symptoms and mortality. At the end of 90 days, all surviving birds were humanely euthanized and their organs examined for lesions at necropsy. The rates of cumulative mortality and tumour generation were used to evaluate the pathogenicity and oncogenicity of the virus mutants.
Determination of the viraemia. To ensure that infection was successful and to evaluate the in vivo propagation of MDVs, the level of viraemia of MDV-challenged chickens was monitored over the duration of the study. Blood samples were collected in anticoagulant from three birds randomly selected from each of the groups at 1, 3, 5, 7, 14, 21, 30, 45, 60, 75 and 90 days p.i., and the virus copy numbers were determined by qRT-PCR as described above.
Evaluation of effects of virus infection on body and organ mass. In order to evaluate the effects of virus infection on the bird's growth, the body masses of six birds randomly selected from each group were obtained at 1, 3, 5, 7, 14, 21, 30, 45, 60, 75 and 90 days p.i. For determining the lymphoid organ mass, six birds from each group were sacrificed on days 1, 3, 5, 7, 14 and 21 post-challenge and their bursa and thymus collected and weighed.
Pathological lesions and tumour induction by MDVs. At 30, 60 and 90 days p.i., three randomly selected birds showing no gross organic tumours from each experimental group were humanely euthanized. Spleens and livers were collected, fixed in 10 % formalin and processed for embedding in paraffin. Four to seven micrometre thick sections of the tissues were prepared and stained with haematoxylin and eosin (HE). After staining, tissue sections were examined for lesions and tumour deposits using a DM6000 light microscope (Leica).
Statistics. The differences in body mass, immune organ mass, mortality and tumour incidence between groups challenged with different MDV strains were compared and analysed by one way ANOVA (LSD) and were considered significant at a probability of P,0.05.
